Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Assets Average (2021 - 2025)

Historic Assets Average for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to $494.1 million.

  • Cytek Biosciences' Assets Average rose 136.29% to $494.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.1 million, marking a year-over-year increase of 136.29%. This contributed to the annual value of $497.0 million for FY2024, which is 197.01% down from last year.
  • Cytek Biosciences' Assets Average amounted to $494.1 million in Q3 2025, which was up 136.29% from $488.0 million recorded in Q2 2025.
  • Cytek Biosciences' Assets Average's 5-year high stood at $524.8 million during Q2 2023, with a 5-year trough of $342.3 million in Q3 2021.
  • Over the past 5 years, Cytek Biosciences' median Assets Average value was $493.3 million (recorded in 2024), while the average stood at $487.3 million.
  • As far as peak fluctuations go, Cytek Biosciences' Assets Average soared by 4491.87% in 2022, and later plummeted by 703.46% in 2024.
  • Cytek Biosciences' Assets Average (Quarter) stood at $458.8 million in 2021, then rose by 11.02% to $509.4 million in 2022, then dropped by 0.48% to $506.9 million in 2023, then dropped by 2.28% to $495.4 million in 2024, then fell by 0.25% to $494.1 million in 2025.
  • Its last three reported values are $494.1 million in Q3 2025, $488.0 million for Q2 2025, and $491.0 million during Q1 2025.